These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 12010857

  • 1. The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.
    Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Venter DJ, Southey MC, Chenevix-Trench G.
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):439-43. PubMed ID: 12010857
    [Abstract] [Full Text] [Related]

  • 2. The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women.
    Spurdle AB, Hopper JL, Chen X, Dite GS, McCredie MR, Giles GG, Venter DJ, Southey MC, Purdie DM, Chenevix-Trench G.
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1287-93. PubMed ID: 11751447
    [Abstract] [Full Text] [Related]

  • 3. Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50.
    Wang-Gohrke S, Chang-Claude J, Becher H, Kieback DG, Runnebaum IB.
    Cancer Res; 2000 May 01; 60(9):2348-50. PubMed ID: 10811106
    [Abstract] [Full Text] [Related]

  • 4. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.
    Suter NM, Malone KE, Daling JR, Doody DR, Ostrander EA.
    Cancer Epidemiol Biomarkers Prev; 2003 Feb 01; 12(2):127-35. PubMed ID: 12582022
    [Abstract] [Full Text] [Related]

  • 5. Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.
    Johnatty SE, Spurdle AB, Beesley J, Chen X, Hopper JL, Duffy DL, Chenevix-Trench G, Kathleen Cuningham Consortium for Research in Familial Breast Cancer.
    Breast Cancer Res Treat; 2008 May 01; 109(1):91-9. PubMed ID: 17592773
    [Abstract] [Full Text] [Related]

  • 6. The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years.
    Spurdle AB, Hopper JL, Chen X, Dite GS, Cui J, McCredie MR, Giles GG, Ellis-Steinborner S, Venter DJ, Newman B, Southey MC, Chenevix-Trench G.
    Cancer Epidemiol Biomarkers Prev; 2002 Apr 01; 11(4):413-6. PubMed ID: 11927503
    [Abstract] [Full Text] [Related]

  • 7. Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer.
    Webb PM, Hopper JL, Newman B, Chen X, Kelemen L, Giles GG, Southey MC, Chenevix-Trench G, Spurdle AB.
    Cancer Epidemiol Biomarkers Prev; 2005 Feb 01; 14(2):319-23. PubMed ID: 15734952
    [Abstract] [Full Text] [Related]

  • 8. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
    Naidu R, Har YC, Taib NA.
    J Exp Clin Cancer Res; 2007 Mar 01; 26(1):133-40. PubMed ID: 17550142
    [Abstract] [Full Text] [Related]

  • 9. A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk.
    De Vivo I, Hankinson SE, Colditz GA, Hunter DJ.
    Cancer Res; 2003 Sep 01; 63(17):5236-8. PubMed ID: 14500352
    [Abstract] [Full Text] [Related]

  • 10. CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk.
    Han S, Lee KM, Choi JY, Park SK, Lee JY, Lee JE, Noh DY, Ahn SH, Han W, Kim DH, Hong YC, Ha E, Yoo KY, Kang D.
    Breast Cancer Res Treat; 2008 Jul 01; 110(2):387-93. PubMed ID: 17940865
    [Abstract] [Full Text] [Related]

  • 11. Association of breast cancer risk with a GT dinucleotide repeat polymorphism upstream of the estrogen receptor-alpha gene.
    Cai Q, Gao YT, Wen W, Shu XO, Jin F, Smith JR, Zheng W.
    Cancer Res; 2003 Sep 15; 63(18):5727-30. PubMed ID: 14522892
    [Abstract] [Full Text] [Related]

  • 12. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP.
    Breast Cancer Res Treat; 2007 Jan 15; 101(1):73-81. PubMed ID: 16807674
    [Abstract] [Full Text] [Related]

  • 13. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
    Shu XO, Cai Q, Gao YT, Wen W, Jin F, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 15; 12(12):1462-7. PubMed ID: 14693738
    [Abstract] [Full Text] [Related]

  • 14. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
    Ren Z, Cai Q, Shu XO, Cai H, Li C, Yu H, Gao YT, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2004 Aug 15; 13(8):1290-5. PubMed ID: 15298948
    [Abstract] [Full Text] [Related]

  • 15. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.
    Ericson U, Sonestedt E, Ivarsson MI, Gullberg B, Carlson J, Olsson H, Wirfält E.
    Cancer Epidemiol Biomarkers Prev; 2009 Apr 15; 18(4):1101-10. PubMed ID: 19336565
    [Abstract] [Full Text] [Related]

  • 16. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
    Quick SK, Shields PG, Nie J, Platek ME, McCann SE, Hutson AD, Trevisan M, Vito D, Modali R, Lehman TA, Seddon M, Edge SB, Marian C, Muti P, Freudenheim JL.
    Cancer Epidemiol Biomarkers Prev; 2008 May 15; 17(5):1082-7. PubMed ID: 18483329
    [Abstract] [Full Text] [Related]

  • 17. The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women.
    Montgomery KG, Chang JH, Gertig DM, Dite GS, McCredie MR, Giles GG, Southey MC, Hopper JL, Campbell IG.
    Breast Cancer Res; 2005 May 15; 7(3):R353-6. PubMed ID: 15987430
    [Abstract] [Full Text] [Related]

  • 18. Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
    Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H, Chen M, Lippert R, Halldorsson BV, Woodworth B, White T, Clark AG, Parl FF, Broder S, Dean M, Offit K.
    Cancer Res; 2004 Dec 15; 64(24):8891-900. PubMed ID: 15604249
    [Abstract] [Full Text] [Related]

  • 19. Association of cyclin D1 genotype with breast cancer risk and survival.
    Shu XO, Moore DB, Cai Q, Cheng J, Wen W, Pierce L, Cai H, Gao YT, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2005 Jan 15; 14(1):91-7. PubMed ID: 15668481
    [Abstract] [Full Text] [Related]

  • 20. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
    Choi JY, Lee KM, Park SK, Noh DY, Ahn SH, Chung HW, Han W, Kim JS, Shin SG, Jang IJ, Yoo KY, Hirvonen A, Kang D.
    Cancer Epidemiol Biomarkers Prev; 2005 May 15; 14(5):1090-5. PubMed ID: 15894657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.